Futibatinib 4mg tablets

SNOMED code
44930911000001107
Active compound
Futibatinib
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 tablet, tablet
Ingredients
Futibatinib — 4 mg based on ingredient substance
Form & Route
tablet.oral
Oral tablet, Oral
Controlled drug
No Controlled Drug Status

Products

Lytgobi 4mg tablets (Taiho Pharma Europe Ltd)

Lytgobi 4mg tablets

SNOMED code
44930311000001106
Supplier
Taiho Pharma Europe Ltd
Licensed as
Medicines - MHRA/EMA
EMA (European Medicines Agency) Monitoring
Yes, black triangle marked
Availability restrictions
None
Licensed route
Oral
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Lytgobi 4mg tablets (Taiho Pharma Europe Ltd) 35 tablet
44930411000001104   ref. pack
💯 Available

Legal category: POM
08470007632221

End: 5061069970005
NHS Indicative Price
£2,386
  • • Prescription Charges
  • • Dispensing Fees
  • • Broken Bulk
  • • Discount not deducted - automatic
Lytgobi 4mg tablets (Taiho Pharma Europe Ltd) 28 tablet
45603211000001107   ref. pack
💯 Available

Legal category: POM
5061069970012
NHS Indicative Price
£2,386
  • • Prescription Charges
  • • Dispensing Fees
  • • Broken Bulk
  • • Discount not deducted - automatic
Lytgobi 4mg tablets (Taiho Pharma Europe Ltd) 21 tablet
45603311000001104   ref. pack
💯 Available

Legal category: POM
5061069970029
NHS Indicative Price
£2,386
  • • Prescription Charges
  • • Dispensing Fees
  • • Broken Bulk
  • • Discount not deducted - automatic

Reference packs

Futibatinib 4mg tablets 21 tablet
SNOMED code
45603011000001102
Quantity and unit
21 tablet
Packs
Futibatinib 4mg tablets 28 tablet
SNOMED code
45603111000001101
Quantity and unit
28 tablet
Packs
Futibatinib 4mg tablets 35 tablet
SNOMED code
44930211000001103
Quantity and unit
35 tablet
Packs